Literature DB >> 11873514

Nitroxides as radiation protectors.

James B Mitchell1, Murali C Krishna.   

Abstract

Selective protection of normal tissues from the damaging effects of ionizing radiation is an important objective in cancer treatment research. Likewise, radioprotective agents may be useful in protecting the human population in the event of radiation-related accidents or military conflicts. Over the past decade, we have identified stable nitroxide compounds as a unique class of antioxidants with demonstrated radioprotective properties. We have shown that nitroxides at nontoxic concentrations are effective as in vitro and in vivo antioxidants when oxidation is induced by superoxide, hydrogen peroxide, organic hydroperoxides, ionizing radiation, or specific DNA-damaging anticancer agents. Studies have shown that nitroxides protect against radiation-induced DNA damage, chromosome aberrations, mutation induction, cell killing, and lethality in mice that receive whole-body irradiation. Whether these agents provide radioprotection for low-level radiation doses remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11873514

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  8 in total

1.  Mg ATP and antioxidants augment the radioprotective effect of surfactant copolymers.

Authors:  Alexander P Soneru; Michael A Beckett; Ralph R Weichselbaum; Raphael C Lee
Journal:  Health Phys       Date:  2011-12       Impact factor: 1.316

2.  Protection of normal brain cells from γ-irradiation-induced apoptosis by a mitochondria-targeted triphenyl-phosphonium-nitroxide: a possible utility in glioblastoma therapy.

Authors:  Zhentai Huang; Jianfei Jiang; Natalia A Belikova; Detcho A Stoyanovsky; Valerian E Kagan; Arlan H Mintz
Journal:  J Neurooncol       Date:  2010-09-12       Impact factor: 4.130

3.  The effects of resveratrol and selected metabolites on the radiation and antioxidant response.

Authors:  Kristin M Fabre; Keita Saito; William DeGraff; Anastasia L Sowers; Angela Thetford; John A Cook; Murali C Krishna; James B Mitchell
Journal:  Cancer Biol Ther       Date:  2011-11-15       Impact factor: 4.742

4.  Radioprotection in vitro and in vivo by minicircle plasmid carrying the human manganese superoxide dismutase transgene.

Authors:  Xichen Zhang; Michael W Epperly; Mark A Kay; Zhi-Ying Chen; Tracy Dixon; Darcy Franicola; Benjamin A Greenberger; Paavani Komanduri; Joel S Greenberger
Journal:  Hum Gene Ther       Date:  2008-08       Impact factor: 5.695

5.  A mitochondria-targeted triphenylphosphonium-conjugated nitroxide functions as a radioprotector/mitigator.

Authors:  Jianfei Jiang; Detcho A Stoyanovsky; Natalia A Belikova; Yulia Y Tyurina; Qing Zhao; Muhammad A Tungekar; Valentyna Kapralova; Zhentai Huang; Arlan H Mintz; Joel S Greenberger; Valerian E Kagan
Journal:  Radiat Res       Date:  2009-12       Impact factor: 2.841

6.  Mitochondrial targeting of a catalase transgene product by plasmid liposomes increases radioresistance in vitro and in vivo.

Authors:  Michael W Epperly; J A Melendez; Xichen Zhang; Suhua Nie; Linda Pearce; James Peterson; Darcy Franicola; Tracy Dixon; Benjamin A Greenberger; Paavani Komanduri; Hong Wang; Joel S Greenberger
Journal:  Radiat Res       Date:  2009-05       Impact factor: 2.841

7.  Modulation of radiation-induced life shortening by systemic intravenous MnSOD-plasmid liposome gene therapy.

Authors:  Michael W Epperly; Tracy Dixon; Hong Wang; James Schlesselman; Darcy Franicola; Joel S Greenberger
Journal:  Radiat Res       Date:  2008-10       Impact factor: 2.841

8.  A mitochondria-targeted nitroxide/hemigramicidin S conjugate protects mouse embryonic cells against gamma irradiation.

Authors:  Jianfei Jiang; Natalia A Belikova; Adam T Hoye; Qing Zhao; Michael W Epperly; Joel S Greenberger; Peter Wipf; Valerian E Kagan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-01       Impact factor: 7.038

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.